Global Cancer Photodynamic Therapy Market Overview:
Photodynamic remedy makes use of a drug that is activated with the aid of light, known as a photosensitizer or photosensitizing agent, to kill most cancers cells. The mild can come from a laser or different source, such as LEDs. Photodynamic remedy is additionally known as PDT. Depending on the phase of the physique being treated, the photosensitizing agent is both put into the bloodstream thru a vein and put on the skin. Over a positive quantity of time the drug is absorbed through the most cancers cells. Then mild is utilized to the location to be treated. The mild motives the drug to react and shape a unique variety of oxygen molecule that kills the cells. PDT may additionally assist through destroying the blood vessels that feed the most cancers cells and by using alerting the immune device to assault the cancer.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Developing Improved Formulations of Porphyrin-Derivative (PD) Compounds
Market Growth Drivers:
Increasing Prevalence of Skin Cancer and Advancements in Device Technologies
Challenges:
Companies Are Increasing Their Production Capabilities to Improve the Efficacy of Novel Delivery Systems in Photodynamic Therapy
Restraints:
High Cost of Photodynamic Therapy Devices and Stringent Regulatory Policies and Risk Associated With the Photodynamic Therapy
Opportunities:
Rising Prevalence of Skin Cancer Is Expected To Fuel the Growth of the Photodynamic Therapy Market
Competitive Landscape:
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.
Some of the key players profiled in the report are Theralase Technologies Inc. (Canada), Biofrontera AG (Germany), Hologic Inc. (United States), Bausch Health (Canada), Quest PharmaTech Inc. (Canada), LUMIBIRD (France), Galderma Laboratories L.P. (Switzerland), Sun Pharmaceutical Industries Limited (India), Allergan plc (Ireland) and Modulight Inc. (Finland). Additionally, following companies can also be profiled that are part of our coverage like SUS Advancing Technology Co. Ltd (China), Lumenis Ltd. (Israel), PhotoMedex Inc. (United States), Dusa Pharmaceuticals (United States) and Soligenix Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Cancer Photodynamic Therapy market by 2028. Considering Market by End-users, the sub-segment i.e. Hospitals will boost the Cancer Photodynamic Therapy market. Considering Market by Side Effects, the sub-segment i.e. Cough will boost the Cancer Photodynamic Therapy market.
Latest Market Insights:
In 2019, Biofrontera AG, a German-based biopharmaceutical player, launched its Phase III scientific trial assessing the protection and effectiveness of photodynamic remedy with Ameluz and the BF-RhodoLED lamp for the use in the analysis of actinic keratoses (AK).
What Can be Explored with the Cancer Photodynamic Therapy Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Cancer Photodynamic Therapy Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Cancer Photodynamic Therapy
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cancer Photodynamic Therapy market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cancer Photodynamic Therapy market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Cancer Photodynamic Therapy Provider, Venture Capitalists and Private Equity Firms, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.